Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 254

1.

Sorting and magnetic-based isolation of reticulated platelets from peripheral blood.

Bernlochner I, Klug M, Larasati D, Von Scheidt M, Santovito D, Hristov M, Weber C, Laugwitz KL, Bongiovanni D.

Platelets. 2020 Feb 11:1-7. doi: 10.1080/09537104.2020.1724923. [Epub ahead of print]

PMID:
32046562
2.

Risk Prediction After Myocardial Infarction by Cyclic Variation of Heart Rate, a Surrogate of Sleep-Disordered Breathing Assessed From Holter ECGs.

Cao X, Müller A, Dirschinger RJ, Dommasch M, Steger A, Barthel P, Laugwitz KL, Schmidt G, Sinnecker D.

Front Physiol. 2020 Jan 15;10:1570. doi: 10.3389/fphys.2019.01570. eCollection 2019.

3.

Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy.

Moretti A, Fonteyne L, Giesert F, Hoppmann P, Meier AB, Bozoglu T, Baehr A, Schneider CM, Sinnecker D, Klett K, Fröhlich T, Rahman FA, Haufe T, Sun S, Jurisch V, Kessler B, Hinkel R, Dirschinger R, Martens E, Jilek C, Graf A, Krebs S, Santamaria G, Kurome M, Zakhartchenko V, Campbell B, Voelse K, Wolf A, Ziegler T, Reichert S, Lee S, Flenkenthaler F, Dorn T, Jeremias I, Blum H, Dendorfer A, Schnieke A, Krause S, Walter MC, Klymiuk N, Laugwitz KL, Wolf E, Wurst W, Kupatt C.

Nat Med. 2020 Feb;26(2):207-214. doi: 10.1038/s41591-019-0738-2. Epub 2020 Jan 27.

PMID:
31988462
4.

Relation of Hypocholesterolemia With Diabetes Mellitus in Patients With Coronary Artery Disease.

Ndrepepa G, Cassese S, Xhepa E, Fusaro M, Laugwitz KL, Schunkert H, Kastrati A.

Am J Cardiol. 2020 Jan 8. pii: S0002-9149(20)30011-4. doi: 10.1016/j.amjcard.2019.12.044. [Epub ahead of print]

PMID:
31955829
5.

Predicting factors for long-term survival in patients with out-of-hospital cardiac arrest - A propensity score-matched analysis.

Lahmann AL, Bongiovanni D, Berkefeld A, Kettern M, Martinez L, Okrojek R, Hoppmann P, Laugwitz KL, Mayr P, Cassese S, Byrne R, Kufner S, Xhepa E, Schunkert H, Kastrati A, Joner M.

PLoS One. 2020 Jan 15;15(1):e0218634. doi: 10.1371/journal.pone.0218634. eCollection 2020.

6.
7.

Impact of transcatheter mitral valve repair using MitraClip on right ventricular remodeling.

Ledwoch J, Fellner C, Hoppmann P, Thalmann R, Kossmann H, Dommasch M, Dirschinger R, Stundl A, Laugwitz KL, Kupatt C.

Int J Cardiovasc Imaging. 2020 Jan 13. doi: 10.1007/s10554-020-01771-2. [Epub ahead of print]

PMID:
31933101
8.

Endovascular therapy of subclavian artery occlusive disease involving the vertebral artery origin.

Schneider V, Dirschinger R, Wustrow I, Müller A, Cassese S, Fusaro M, Kastrati A, Koppara T, Bergmann K, Laugwitz KL, Ibrahim T, Bradaric C.

Vasa. 2020 Jan 6:1-9. doi: 10.1024/0301-1526/a000842. [Epub ahead of print]

PMID:
31904303
9.

Long-term transesophageal echocardiography follow-up after percutaneous left atrial appendage closure.

Staubach S, Schlatterbeck L, Mörtl M, Strohm H, Hoppmann P, Laugwitz KL, Mudra H, Ledwoch J.

Heart Rhythm. 2019 Dec 11. pii: S1547-5271(19)31096-3. doi: 10.1016/j.hrthm.2019.12.004. [Epub ahead of print]

PMID:
31841716
10.

Efficacy of drug-coated balloon angioplasty in early versus late occurring drug-eluting stent restenosis: A pooled analysis from the randomized ISAR DESIRE 3 and DESIRE 4 trials.

Koch T, Cassese S, Xhepa E, Mayer K, Tölg R, Hoppmann P, Laugwitz KL, Byrne RA, Kastrati A, Kufner S.

Catheter Cardiovasc Interv. 2019 Dec 2. doi: 10.1002/ccd.28638. [Epub ahead of print]

PMID:
31789486
11.

Ticagrelor-based antiplatelet regimens in patients with atherosclerotic artery disease-A meta-analysis of randomized clinical trials.

Cassese S, Ndrepepa G, Byrne RA, Laugwitz KL, Schunkert H, Fusaro M, Alfonso F, Kastrati A.

Am Heart J. 2020 Jan;219:109-116. doi: 10.1016/j.ahj.2019.08.020. Epub 2019 Aug 31.

PMID:
31756624
12.

Association of shock index with short-term and long-term prognosis after ST-segment elevation myocardial infarction.

Ndrepepa G, Cassese S, Xhepa E, Fusaro M, Laugwitz KL, Schunkert H, Kastrati A.

Coron Artery Dis. 2019 Dec;30(8):575-583. doi: 10.1097/MCA.0000000000000802.

PMID:
31577621
13.

Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.

Schüpke S, Neumann FJ, Menichelli M, Mayer K, Bernlochner I, Wöhrle J, Richardt G, Liebetrau C, Witzenbichler B, Antoniucci D, Akin I, Bott-Flügel L, Fischer M, Landmesser U, Katus HA, Sibbing D, Seyfarth M, Janisch M, Boncompagni D, Hilz R, Rottbauer W, Okrojek R, Möllmann H, Hochholzer W, Migliorini A, Cassese S, Mollo P, Xhepa E, Kufner S, Strehle A, Leggewie S, Allali A, Ndrepepa G, Schühlen H, Angiolillo DJ, Hamm CW, Hapfelmeier A, Tölg R, Trenk D, Schunkert H, Laugwitz KL, Kastrati A; ISAR-REACT 5 Trial Investigators.

N Engl J Med. 2019 Oct 17;381(16):1524-1534. doi: 10.1056/NEJMoa1908973. Epub 2019 Sep 1.

PMID:
31475799
14.

Transcriptome Analysis of Reticulated Platelets Reveals a Prothrombotic Profile.

Bongiovanni D, Santamaria G, Klug M, Santovito D, Felicetta A, Hristov M, von Scheidt M, Aslani M, Cibella J, Weber C, Moretti A, Laugwitz KL, Peano C, Bernlochner I.

Thromb Haemost. 2019 Nov;119(11):1795-1806. doi: 10.1055/s-0039-1695009. Epub 2019 Sep 1.

PMID:
31473989
15.

Incidence and predictors of stent thrombosis after endovascular revascularisation of the superficial femoral artery.

Bradaric C, Koppara T, Müller A, Haller B, Ott I, Cassese S, Fusaro M, Kastrati A, Laugwitz KL, Ibrahim T.

EuroIntervention. 2019 Dec 20;15(12):e1107-e1114. doi: 10.4244/EIJ-D-19-00187.

16.

Evaluation of a shortened cardiac MRI protocol for left ventricular examinations: diagnostic performance of T1-mapping and myocardial function analysis.

Nadjiri J, Zaschka AL, Straeter AS, Sauter A, Englmaier M, Weis F, Laugwitz KL, Rummeny EJ, Pfeiffer D, Rasper M.

BMC Med Imaging. 2019 Jul 24;19(1):57. doi: 10.1186/s12880-019-0358-9.

17.

Inverse association of alanine aminotransferase within normal range with prognosis in patients with coronary artery disease.

Ndrepepa G, Holdenrieder S, Colleran R, Cassese S, Xhepa E, Fusaro M, Laugwitz KL, Schunkert H, Kastrati A.

Clin Chim Acta. 2019 Sep;496:55-61. doi: 10.1016/j.cca.2019.06.021. Epub 2019 Jun 27.

PMID:
31254501
18.

Very late scaffold thrombosis after everolimus-eluting bioresorbable scaffold implantation in patients with unremarkable interim surveillance angiography.

Hoppmann P, Rai H, Colleran R, Kufner S, Wiebe J, Cassese S, Joner M, Laugwitz KL, Kastrati A, Byrne RA.

Cardiovasc Revasc Med. 2019 May 30. pii: S1553-8389(19)30322-7. doi: 10.1016/j.carrev.2019.05.023. [Epub ahead of print]

PMID:
31231028
19.

Revacept, a Novel Inhibitor of Platelet Adhesion, in Patients Undergoing Elective PCI-Design and Rationale of the Randomized ISAR-PLASTER Trial.

Schüpke S, Hein-Rothweiler R, Mayer K, Janisch M, Sibbing D, Ndrepepa G, Hilz R, Laugwitz KL, Bernlochner I, Gschwendtner S, Kupka D, Gori T, Zeiher AM, Schunkert H, Massberg S, Kastrati A; ISAR-PLASTER-Trial Investigators.

Thromb Haemost. 2019 Sep;119(9):1539-1545. doi: 10.1055/s-0039-1692423. Epub 2019 Jun 21.

PMID:
31226721
20.

Time-of-day at symptom onset was not associated with infarct size and long-term prognosis in patients with ST-segment elevation myocardial infarction.

Sager HB, Husser O, Steffens S, Laugwitz KL, Schunkert H, Kastrati A, Ndrepepa G, Kessler T.

J Transl Med. 2019 May 29;17(1):180. doi: 10.1186/s12967-019-1934-z.

21.

Prognostic Impact of Left Atrial Function Following Transcatheter Mitral Valve Repair.

Ledwoch J, Leidgschwendner K, Fellner C, Poch F, Olbrich I, Thalmann R, Kossmann H, Dommasch M, Dirschinger R, Stundl A, Laugwitz KL, Kupatt C, Hoppmann P.

J Am Heart Assoc. 2019 May 7;8(9):e011727. doi: 10.1161/JAHA.118.011727.

22.

Monocyte-platelet aggregates affect local inflammation in patients with acute myocardial infarction.

Kossmann H, Rischpler C, Hanus F, Nekolla SG, Kunze KP, Götze K, Goedel A, Sager H, Kastrati A, Sinnecker D, Kupatt C, Ibrahim T, Schwaiger M, Laugwitz KL, Dirschinger RJ.

Int J Cardiol. 2019 Jul 15;287:7-12. doi: 10.1016/j.ijcard.2019.04.009. Epub 2019 Apr 8.

PMID:
31003796
23.

Reverse Cardiac Remodeling After Transcatheter Treatment of Severe Tricuspid Regurgitation Using the Edge-to-Edge MitraClip Technique.

Ledwoch J, Fellner C, Poch F, Schlatterbeck L, Dommasch M, Dirschinger R, Stundl A, Laugwitz KL, Kupatt C, Hoppmann P.

J Invasive Cardiol. 2019 Apr;31(4):89-93.

24.

Do outcomes following intervention for drug-eluting stent restenosis depend on whether the restenosed stent was polymer-free or polymer-coated?

Harada Y, Schneider S, Colleran R, Rai H, Bohner J, Kuna C, Kufner S, Giacoppo D, Schüpke S, Joner M, Ibrahim T, Laugwitz KL, Kastrati A, Byrne RA.

Rev Esp Cardiol (Engl Ed). 2019 Mar 13. pii: S1885-5857(19)30029-5. doi: 10.1016/j.rec.2019.01.005. [Epub ahead of print] English, Spanish.

PMID:
30878234
25.

Enhanced platelet inhibition by clopidogrel and risk of bleeding in patients requiring oral anticoagulation after drug-eluting stent implantation.

Goedel A, Fiedler KA, Mehilli J, Bernlochner I, von Olshausen G, Mayer K, Schüpke S, Hoppmann P, Sibbing D, Maeng M, Massberg S, Schunkert H, Laugwitz KL, Kastrati A, Sarafoff N.

EuroIntervention. 2019 Oct 20;15(8):700-706. doi: 10.4244/EIJ-D-18-00995.

26.

The Wnt inhibitor Dkk1 is required for maintaining the normal cardiac differentiation program in Xenopus laevis.

Guo Y, Dorn T, Kühl SJ, Linnemann A, Rothe M, Pfister AS, Vainio S, Laugwitz KL, Moretti A, Kühl M.

Dev Biol. 2019 May 1;449(1):1-13. doi: 10.1016/j.ydbio.2019.02.009. Epub 2019 Feb 21.

27.

Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention.

Kessler T, Wolf B, Eriksson N, Kofink D, Mahmoodi BK, Rai H, Tragante V, Åkerblom A, Becker RC, Bernlochner I, Bopp R, James S, Katus HA, Mayer K, Munz M, Nordio F, O'Donoghue ML, Sager HB, Sibbing D, Solakov L, Storey RF, Wobst J, Asselbergs FW, Byrne RA, Erdmann J, Koenig W, Laugwitz KL, Ten Berg JM, Wallentin L, Kastrati A, Schunkert H.

Cardiovasc Res. 2019 Aug 1;115(10):1512-1518. doi: 10.1093/cvr/cvz015.

PMID:
30768153
28.

Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents. A pooled analysis of individual patient data from 2 randomized trials.

Cassese S, Katagiri Y, Byrne RA, Brugaletta S, Alfonso F, Räber L, Maeng M, Iñiguez A, Kretov E, Onuma Y, Joner M, Sabaté M, Laugwitz KL, Windecker S, Kastrati A, Serruys PW.

EuroIntervention. 2019 Feb 5. pii: EIJ-D-18-01080. doi: 10.4244/EIJ-D-18-01080. [Epub ahead of print]

29.

Relationship of left ventricular end-diastolic pressure with extent of myocardial ischemia, myocardial salvage and long-term outcome in patients with ST-segment elevation myocardial infarction.

Ndrepepa G, Cassese S, Hashorva D, Kufner S, Xhepa E, Hasimi E, Fusaro M, Laugwitz KL, Schunkert H, Kastrati A.

Catheter Cardiovasc Interv. 2019 Apr 1;93(5):901-909. doi: 10.1002/ccd.28098. Epub 2019 Jan 25.

PMID:
30680881
30.

U-shaped association of central pulse pressure with long-term prognosis after ST-segment elevation myocardial infarction.

Ndrepepa G, Cassese S, Kufner S, Xhepa E, Fusaro M, Laugwitz KL, Schunkert H, Kastrati A.

Heart Vessels. 2019 Jul;34(7):1104-1112. doi: 10.1007/s00380-019-01344-x. Epub 2019 Jan 22.

PMID:
30671640
31.

Ten-Year Clinical Outcomes From a Trial of Three Limus-Eluting Stents With Different Polymer Coatings in Patients With Coronary Artery Disease.

Kufner S, Joner M, Thannheimer A, Hoppmann P, Ibrahim T, Mayer K, Cassese S, Laugwitz KL, Schunkert H, Kastrati A, Byrne RA; ISAR-TEST 4 (Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents) Investigators.

Circulation. 2019 Jan 15;139(3):325-333. doi: 10.1161/CIRCULATIONAHA.118.038065.

PMID:
30586724
32.

Accuracy of Calcium Scoring calculated from contrast-enhanced Coronary Computed Tomography Angiography using a dual-layer spectral CT: A comparison of Calcium Scoring from real and virtual non-contrast data.

Nadjiri J, Kaissis G, Meurer F, Weis F, Laugwitz KL, Straeter AS, Muenzel D, Noël PB, Rummeny EJ, Rasper M.

PLoS One. 2018 Dec 6;13(12):e0208588. doi: 10.1371/journal.pone.0208588. eCollection 2018.

33.

Prospective, randomized trial of bioresorbable scaffolds vs. everolimus-eluting stents in patients undergoing coronary stenting for myocardial infarction: the Intracoronary Scaffold Assessment a Randomized evaluation of Absorb in Myocardial Infarction (ISAR-Absorb MI) trial.

Byrne RA, Alfonso F, Schneider S, Maeng M, Wiebe J, Kretov E, Bradaric C, Rai H, Cuesta J, Rivero F, Hoppmann P, Schlichtenmaier J, Christiansen EH, Cassese S, Joner M, Schunkert H, Laugwitz KL, Kastrati A.

Eur Heart J. 2019 Jan 7;40(2):167-176. doi: 10.1093/eurheartj/ehy710.

PMID:
30520980
34.

Relation of Ratio of Left Ventricular Ejection Fraction to Left Ventricular End-Diastolic Pressure to Long-Term Prognosis After ST-Segment Elevation Acute Myocardial Infarction.

Ndrepepa G, Cassese S, Emmer M, Mayer K, Kufner S, Xhepa E, Fusaro M, Laugwitz KL, Schunkert H, Kastrati A.

Am J Cardiol. 2019 Jan 15;123(2):199-205. doi: 10.1016/j.amjcard.2018.10.007. Epub 2018 Oct 23.

PMID:
30424868
35.

Comparison of Vascular Closure Devices Versus Manual Compression After Femoral Artery Puncture in Women.

Gewalt SM, Helde SM, Ibrahim T, Mayer K, Schmidt R, Bott-Flügel L, Hoppe K, Ott I, Hieber J, Morath T, Byrne RA, Kufner S, Cassese S, Hoppmann P, Fusaro M, Schunkert H, Laugwitz KL, Kastrati A, Schüpke S; Instrumental Sealing of Arterial Puncture Site—CLOSURE Device Versus Manual Compression (ISAR-CLOSURE) Trial Investigators.

Circ Cardiovasc Interv. 2018 Aug;11(8):e006074. doi: 10.1161/CIRCINTERVENTIONS.117.006074.

PMID:
30354782
36.

Sex and long-term outcomes after implantation of the Absorb bioresorbable vascular scaffold for treatment of coronary artery disease.

Baquet M, Hoppmann P, Grundmann D, Schmidt W, Kufner S, Theiss HD, Brunner S, Wiebe J, Eickhoff M, Jochheim D, Byrne RA, Laugwitz KL, Schunkert H, Massberg S, Kastrati A, Mehilli J.

EuroIntervention. 2019 Sep 20;15(7):615-622. doi: 10.4244/EIJ-D-18-00603.

37.

Aberrant Deactivation-Induced Gain of Function in TRPM4 Mutant Is Associated with Human Cardiac Conduction Block.

Xian W, Hui X, Tian Q, Wang H, Moretti A, Laugwitz KL, Flockerzi V, Ruppenthal S, Lipp P.

Cell Rep. 2018 Jul 17;24(3):724-731. doi: 10.1016/j.celrep.2018.06.034.

38.

Real clinical experiences of dual versus triple antithrombotic therapy after percutaneous coronary intervention.

Wustrow I, Sarafoff N, Haller B, Rössner L, Sibbing D, Schüpke S, Ibrahim T, Anetsberger A, Schunkert H, Laugwitz KL, Kastrati A, Bernlochner I.

Catheter Cardiovasc Interv. 2018 Dec 1;92(7):1239-1246. doi: 10.1002/ccd.27678. Epub 2018 Jul 18.

PMID:
30019824
39.

Tβ4 Increases Neovascularization and Cardiac Function in Chronic Myocardial Ischemia of Normo- and Hypercholesterolemic Pigs.

Ziegler T, Bähr A, Howe A, Klett K, Husada W, Weber C, Laugwitz KL, Kupatt C, Hinkel R.

Mol Ther. 2018 Jul 5;26(7):1706-1714. doi: 10.1016/j.ymthe.2018.06.004. Epub 2018 Jun 19.

40.

Spectral Computed Tomography Angiography With a Gadolinium-based Contrast Agent: First Clinical Imaging Results in Cardiovascular Applications.

Nadjiri J, Pfeiffer D, Straeter AS, Noël PB, Fingerle A, Eckstein HH, Laugwitz KL, Rummeny EJ, Braren R, Rasper M.

J Thorac Imaging. 2018 Jul;33(4):246-253. doi: 10.1097/RTI.0000000000000335.

PMID:
29863589
41.

Sex differences in the outcome after percutaneous coronary intervention - A propensity matching analysis.

Ndrepepa G, Kufner S, Mayer K, Cassese S, Xhepa E, Fusaro M, Hasimi E, Schüpke S, Laugwitz KL, Schunkert H, Kastrati A.

Cardiovasc Revasc Med. 2019 Feb;20(2):101-107. doi: 10.1016/j.carrev.2018.05.010. Epub 2018 May 24.

PMID:
29802021
42.

Quantitative cardiovascular magnetic resonance: extracellular volume, native T1 and 18F-FDG PET/CMR imaging in patients after revascularized myocardial infarction and association with markers of myocardial damage and systemic inflammation.

Kunze KP, Dirschinger RJ, Kossmann H, Hanus F, Ibrahim T, Laugwitz KL, Schwaiger M, Rischpler C, Nekolla SG.

J Cardiovasc Magn Reson. 2018 May 24;20(1):33. doi: 10.1186/s12968-018-0454-y.

43.

Interplay of cell-cell contacts and RhoA/MRTF-A signaling regulates cardiomyocyte identity.

Dorn T, Kornherr J, Parrotta EI, Zawada D, Ayetey H, Santamaria G, Iop L, Mastantuono E, Sinnecker D, Goedel A, Dirschinger RJ, My I, Laue S, Bozoglu T, Baarlink C, Ziegler T, Graf E, Hinkel R, Cuda G, Kääb S, Grace AA, Grosse R, Kupatt C, Meitinger T, Smith AG, Laugwitz KL, Moretti A.

EMBO J. 2018 Jun 15;37(12). pii: e98133. doi: 10.15252/embj.201798133. Epub 2018 May 15.

44.

Comparison of the FemoSeal Vascular Closure Device With Manual Compression After Femoral Artery Puncture - Post-hoc Analysis of a Large-Scale, Randomized Clinical Trial.

Mankerious N, Mayer K, Gewalt SM, Helde SM, Ibrahim T, Bott-Flügel L, Laugwitz KL, Schunkert H, Kastrati A, Schüpke S; Instrumental Sealing of ARterial puncture site –CLOSURE device versus manual compression (ISAR-CLOSURE) Trial Investigators.

J Invasive Cardiol. 2018 Jul;30(7):235-239. Epub 2018 May 15.

45.

Efficacy Over Time With Drug-Eluting Stents in Saphenous Vein Graft Lesions.

Colleran R, Kufner S, Mehilli J, Rosenbeiger C, Schüpke S, Hoppmann P, Joner M, Mankerious N, Fusaro M, Cassese S, Abdel-Wahab M, Neumann FJ, Richardt G, Ibrahim T, Schunkert H, Laugwitz KL, Kastrati A, Byrne RA; ISAR-CABG Investigators.

J Am Coll Cardiol. 2018 May 8;71(18):1973-1982. doi: 10.1016/j.jacc.2018.03.456.

46.

Markers of Reperfusion and Long-Term (8-Year) Prognosis after Primary Percutaneous Coronary Intervention.

Ndrepepa G, Byrne RA, Cassese S, Fusaro M, Colleran R, Hieber J, Laugwitz KL, Schunkert H, Kastrati A.

Am J Cardiol. 2018 Jul 1;122(1):39-46. doi: 10.1016/j.amjcard.2018.03.353. Epub 2018 Apr 9.

PMID:
29706204
47.

Myocardial perfusion quantification using simultaneously acquired 13 NH3 -ammonia PET and dynamic contrast-enhanced MRI in patients at rest and stress.

Kunze KP, Nekolla SG, Rischpler C, Zhang SH, Hayes C, Langwieser N, Ibrahim T, Laugwitz KL, Schwaiger M.

Magn Reson Med. 2018 Dec;80(6):2641-2654. doi: 10.1002/mrm.27213. Epub 2018 Apr 19.

PMID:
29672922
48.

High-sensitivity cardiac troponin T and prognosis in patients with ST-segment elevation myocardial infarction.

Ndrepepa G, Kufner S, Hoyos M, Harada Y, Xhepa E, Hieber J, Cassese S, Fusaro M, Laugwitz KL, Schunkert H, Kastrati A.

J Cardiol. 2018 Sep;72(3):220-226. doi: 10.1016/j.jjcc.2018.02.014. Epub 2018 Mar 26.

49.

Randomised comparison of vascular response to biodegradable polymer sirolimus eluting and permanent polymer everolimus eluting stents: An optical coherence tomography study.

Koppara T, Tada T, Xhepa E, Kufner S, Byrne RA, Ibrahim T, Laugwitz KL, Kastrati A, Joner M.

Int J Cardiol. 2018 May 1;258:42-49. doi: 10.1016/j.ijcard.2018.01.011.

PMID:
29544956
50.

Outcomes of patients treated with ultrathin-strut biodegradable polymer sirolimus-eluting stents versus fluoropolymer-based everolimus-eluting stents: a meta-analysis of randomised trials.

Cassese S, Ndrepepa G, Byrne RA, Kufner S, Lahmann AL, Mankerious N, Xhepa E, Laugwitz KL, Schunkert H, Fusaro M, Kastrati A, Joner M.

EuroIntervention. 2018 Jun 20;14(2):224-231. doi: 10.4244/EIJ-D-18-00024.

Supplemental Content

Loading ...
Support Center